Diamond Hill Capital, an investment management company, released its “Small Cap Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fourth quarter posted another period of favorable gains for equity markets, with the Russell 2000 Index returning 2.19%, roughly in line with the Russell 1000 Index’s 2.41% gain. Health care (+18.6%) emerged as the best-performing sector in the Russell 2000 Index. Heightened uncertainty and geopolitical risks contributed to a mixed ma ...

The price offered in the Tender Offers and other information relating to the Tender Offers are set forth in the table below. PASADENA, Calif., Jan. 27, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the commencement of cash tender offers ("Tender Offers") to purchase up to an aggregate principal amount that will not result in an aggregate purchase price that exceeds $800,000,000 (subject to increase or decrease by the Company, the "Aggr ...

Leasing volume of 1.2 million square feet was up 14% versus the prior four-quarter average and up 10% versus the prior eight-quarter average, according to Binda. Leasing of vacant space totaled 393,000 rentable square feet, which he said was nearly double the quarterly average over the last five quarters. However, Binda noted that free rent and rental rate changes on renewed and re-leased space were “under pressure” during the quarter, citing two large deals—one in Canada and one in the Sorrento Mesa submar ...

Financial Data and Key Metrics Changes - For Q4 2025, the diluted FFO per share was $2.16, and for the full year, it was $9.01, aligning with the midpoint of prior guidance [7] - Same property net operating income (NOI) decreased by 6% for Q4 and 3.5% for the full year, with a cash basis decline of 1.7% for Q4 and an increase of 0.9% for the full year [10][11] - Occupancy at the end of 2025 was 90.9%, up 30 basis points from the previous quarter and 10 basis points above prior guidance [9] Business Line Data and Key Metrics Changes - The company completed $1.5 billion in dispositions across 26 transactions and achieved a total leasing volume of 1.2 million sq ft in Q4, the highest in the last year [7] - Leasing of vacant space in Q4 reached 393,000 rentable sq ft, nearly double the average over the last five quarters [8] - The average lease term for the quarter was just over 7.5 years, consistent with the prior three-year average [8] Market Data and Key Metrics Changes - The company noted that its mega campuses, which account for about 78% of annual rental revenue, outperformed total market occupancy in the largest three markets by 19% [9] - The leasing volume for private biotechnology made up about a fifth of all leasing volume in Q4, indicating sustained demand from this segment [66] Company Strategy and Development Direction - The company plans to focus on timely execution of its strategic plan for 2026, emphasizing dispositions, maintaining a strong balance sheet, and reducing capital expenditures [5] - The strategic path forward includes reducing the size of the pipeline and construction spending needs, with a goal to complete a large-scale non-core disposition plan in 2026 [16][20] - The company aims to recycle capital from dispositions and partial interest sales to support funding needs, particularly focusing on non-core assets and land [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the leasing environment, noting that while there are positive signs in venture capital funding, decision-making remains conservative among companies [31][32] - The company anticipates a dip in occupancy in Q1 2026 due to key lease expirations but expects growth in the second half of 2026 [10] - Management reiterated that the public biotech sector's recovery is critical for future leasing demand, as many companies currently have sufficient space [76][78] Other Important Information - The company achieved significant general and administrative cost savings of $51.3 million, or 30% compared to the prior year, with G&A costs as a percentage of NOI at 5.6% for 2025 [15] - The company has a strong balance sheet with liquidity of $5.3 billion and a net debt to adjusted EBITDA ratio of 5.7x for Q4 [18] Q&A Session Summary Question: Impact of VC funding on leasing outlook - Management noted that while there is sustained funding in private biotechnology, the overall environment remains cautious, and decision-making is taking longer [30][32] Question: Strategy regarding The Fenway office property - Management confirmed that retaining The Fenway office property for leasing as office space is a strategic decision based on demand [34][35] Question: Cap rate trends for dispositions - Management indicated that cap rates for non-core assets are in the mid-sixes to mid-nines, depending on market conditions and asset specifics [40] Question: Guidance for FFO in Q4 2026 - Management confirmed that the guidance for Q4 2026 FFO remains at $1.40-$1.60, representing a trough for the year [48][49] Question: Buyer types for dispositions - Management highlighted that the buyer pool includes investment funds and residential developers, with a significant portion of land expected to be sold for residential use [56][57] Question: Capital allocation priorities - Management stated that the priority is on debt reduction through the disposition program before considering stock buybacks [85]

Alexandria Real Estate Equities (NYSE:ARE) Q4 2025 Earnings call January 27, 2026 02:00 PM ET Company ParticipantsFarrell Granath - Equity Research AssociateHallie Kuhn - SVP of Life Science and Capital MarketsJim Kammert - Managing DirectorJoel Marcus - Executive Chairman and FounderJohn Kim - Managing DirectorMarc Binda - CFOMason Guell - Equity Research AssociateMichael Carroll - Managing DirectorPaula Schwartz - Managing DirectorPeter Moglia - CEO and CIORay Zhong - VP of REIT Equity ResearchRich Anders ...

Financial Data and Key Metrics Changes - FFO per share diluted as adjusted was $2.16 for Q4 2025 and $9.01 for the year, aligning with prior guidance [5] - Same property net operating income (NOI) decreased by 6% for Q4 and 3.5% for the full year 2025 [8][10] - Occupancy at the end of 2025 was 90.9%, up 30 basis points from the prior quarter [7] Business Line Data and Key Metrics Changes - Leasing volume for Q4 was 1.2 million sq ft, up 14% over the prior four-quarter average [6] - The leasing of vacant space completed during Q4 was 393,000 rentable sq ft, nearly double the average over the last five quarters [6] - Free rent and rental rate changes on renewed and released space were under pressure, reflecting market realities [6] Market Data and Key Metrics Changes - The company expects occupancy to dip in Q1 2026 due to 1.2 million sq ft of key lease expirations [8] - The company reiterated its year-end 2026 occupancy range of 87.7%-89.3% [7] - The Greater Boston region saw an 11% increase in tenants, marking the first increase in several quarters [33] Company Strategy and Development Direction - The strategic focus for 2026 includes timely execution of plans, maintaining a strong balance sheet, and reducing capital expenditures [4] - The company aims to significantly reduce the size of its pipeline and construction spending needs [13] - The disposition program for 2026 is expected to include a significant component of land, targeting non-core assets [21] Management's Comments on Operating Environment and Future Outlook - Management noted the life science bear market and the challenges posed by regulatory changes and market dynamics [3] - There is cautious optimism regarding venture capital funding, but decision-making remains slow among companies [26] - The company anticipates a recovery in leasing demand but acknowledges the need for more robust public biotech activity [50] Other Important Information - The company achieved general and administrative cost savings of $51.3 million, or 30% compared to the prior year [12] - Realized gains from venture investments were $21 million, down from the previous quarterly average [15] - The company has a strong balance sheet with liquidity of $5.3 billion and a net debt to adjusted EBITDA ratio of 5.7x [16] Q&A Session Summary Question: Impact of VC funding on leasing outlook - Management noted that while there is sustained funding in private biotechnology, the overall environment remains cautious, and decision-making is slower [25][26] Question: Strategy regarding The Fenway office property - Management indicated that retaining The Fenway office property for leasing is specific to that location and not a broader strategy [28] Question: Cap rate trends for dispositions - Management mentioned that cap rates for non-core assets range from mid-sixes to mid-nines, depending on market conditions [31] Question: Leasing pipeline and notable groups - Management highlighted that smaller spaces under 50,000 sq ft are in demand, but there is a lack of activity from public biotech companies [32][33] Question: Guidance for Q4 2026 FFO - Management confirmed that the guidance for Q4 2026 FFO remains at $1.40-$1.60, representing a trough for the year [34][41] Question: Capital allocation priorities - Management stated that the priority is on debt reduction before considering stock buybacks [52]

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2026 Table of Contents December 31, 2025 | COMPANY HIGHLIGHTS | Page | | Page | | | --- | --- | --- | --- | --- | | Alexandria's Mission and Cluster Model | iii | | | CONFERENCE CALL | | | | | | INFORMATION: | | EARNINGS PRESS RELEASE | | | | Tuesday, January 27, 2026 | | Fourth Quarter and Year Ended December 31, 2025 Financial and | | | | 2:00 p.m. Eastern Time | | Operating Results | 1 | Consolidated Statements of Operations | 8 | 11:00 a.m. Pa ...

Key Takeaways ARE posted Q4 AFFO of $2.16 and revenues of $754.4M, topping estimates while both declined year over year.ARE leased 1.2M RSF in Q4; occupancy rose sequentially to 90.9% but was down 3.7% from a year ago.ARE sold $1.47B of assets, delivered a fully leased project, and saw interest expense jump 18% year over year.Alexandria Real Estate Equities, Inc. (ARE) reported fourth-quarter 2025 adjusted funds from operations (AFFO) per share of $2.16, beating the Zacks Consensus Estimate of $2.15. This c ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. During the quarter, the ClearBridge Mid Cap Strategy reported underperformance versus the Russell Midcap Index, which returned 0.16% during the period, as narrow market leadership and sentiment-driven trading weighed on results. Weakness in information technology and real estate holdings pressured returns, while gains in select consumer ...

Group 1 - The REIT market tends to overreact, both positively and negatively, depending on market conditions [1] - High Yield Landlord is offering new members a $100 discount and a 30-day money-back guarantee to attract new investors [1] - The investment group provides features such as three portfolios (core, retirement, international), buy/sell alerts, and direct access to analysts [2] Group 2 - Jussi Askola, the President of Leonberg Capital, has extensive experience in REIT investing and has built relationships with top REIT executives [2] - The group shares real-time transactions and maintains a focus on value-oriented investment strategies [2]